Remarkable features of ovarian morphology and reproductive hormones in insulin-resistant Zucker fatty (fa/fa) rats
© Honnma et al; licensee BioMed Central Ltd. 2010
Received: 13 January 2010
Accepted: 24 June 2010
Published: 24 June 2010
Zucker fatty (fa/fa) rats are a well-understood model of obesity and hyperinsulinemia. It is now thought that obesity/hyperinsulinemia is an important cause of endocrinological abnormality, but to date there have been no reports on the changes in ovarian morphology or the ovarian androgen profile in rat models of obesity and insulin resistance.
In this study we investigated the effects of obesity and hyperinsulinemia on ovarian morphology and the hormone profile in insulin-resistant Zucker fatty rats (5, 8, 12 and 16 weeks of age, n = 6-7).
Ovaries from 5-week-old fatty rats had significantly greater total and atretic follicle numbers, and higher atretic-to-total follicle ratios than those from lean rats. Ovaries from 12- and 16-week-old fatty rats showed interstitial cell hyperplasia and numerous cysts with features of advanced follicular atresia. In addition, serum testosterone and androstenedione levels significantly declined in fatty rats from age 8 to 16 weeks, so that fatty rats showed significantly lower levels of serum testosterone (12 and 16 weeks) and androstenedione (all weeks) than lean rats. This may reflect a reduction of androgen synthesis during follicular atresia. Serum adiponectin levels were high in immature fatty rats, and although the levels declined significantly as they matured, it remained significantly higher in fatty rats than in lean rats. On the other hand, levels of ovarian adiponectin and its receptors were significantly lower in mature fatty rats than in lean mature rats or immature fatty rats.
Our findings indicate that ovarian morphology and hormone profiles are significantly altered by the continuous insulin resistance in Zucker fatty rats. Simultaneously, abrupt reductions in serum and ovarian adiponectin also likely contribute to the infertility seen in fatty rats.
Zucker fatty (fa/fa) rats are a well-understood model of obesity and hyperinsulinemia, which arise when the animals are about 4 weeks of age and gradually worsen thereafter . The cause of the obesity is overeating induced by a loss of leptin signaling associated with a leptin receptor mutation. Zucker fatty rats also have several endocrine and metabolic abnormalities, including a low metabolic rate , hyperinsulinemia [3, 4], abnormal estrous cyclicity  and infertility . They are not diabetic, however. It is now thought that their obesity/hyperinsulinemia is an important cause of their endocrinological abnormality, but to date there have been no reports on the changes in ovarian morphology or the ovarian androgen profile in rat models of obesity and insulin resistance.
Adiponectin is a 30-kDa protein comprised of 247 amino acids in four domains and has been shown to possess insulin-sensitizing [6–8], anti-atherogenic [9, 10] and anti-inflammatory properties . It also reportedly inhibits apoptosis among endothelial cells . Zucker fatty rats show higher serum adiponectin level than lean rats . Adiponectin and its receptors are expressed in rat testis  and ovary [15, 16] and play a significant role in steroidogenesis , but the mechanism underlying the changes in ovarian adiponectin expression caused by obesity/insulin resistance remains unknown. In an earlier study, we reported that by injecting immature rats with androgen (dehydroepiandrosterone), an animal model of polycystic ovary could be produced that exhibits the salient features of human PCOS - i.e., prepubertal female rats develop cysts and become anovulatory and uncyclic , and the follicles undergo atresia or exhibit various stages of cystogenesis up to complete pathological transformation into a follicular cyst [19, 20]. Our aim in the present study, therefore, was to investigate the ovarian morphology and hormone profile in Zucker fatty rats, focusing on serum androgen levels and ovarian adiponectin expression.
Animal treatments and tissue collection
Female Zucker fatty rats (Slc:Zucker-fa/fa) and lean rats (Slc:Zucker-+/+) (4, 7, 11 and 15 weeks of age) were purchased from Japan SLC (Shizuoka, Japan). Vaginal smears were collected each morning by lavage for about 2 weeks to determine estrous cyclicity . Rats were usually sacrificed by decapitation on day 4 of their estrous cycle, in diestrus during day, and after 12 h of fasting (5, 8, 12 and 16 weeks of age). The ovaries were then dissected out, trimmed, weighed, flash-frozen on dry ice, and stored at -80°C until use. Animals used in this study were maintained in accordance with the guidelines of the Animal Resources Center of the Sapporo Medical University School of Medicine.
Serum FSH, LH, estradiol, testosterone and androstenedione levels were determined using RIA kits (DPC Co., Los Angeles, CA) as previously described . Serum adiponectin was measured using a commercially available enzyme-linked immunosorbent assay kit (Otuska Pharmaceuticals Co., Japan).
TdT-mediated dUTP-biotin nick end-labeling (TUNEL)
TUNEL was carried out using an ApopTag Plus Peroxidase In Situ Apoptosis Detection Kit (Intergen, NY) as described previously . Tissue samples embedded in paraffin were cut into 5-μm-thick sections, which were then deparaffinized in xylene and rehydrated through a graded ethanol series in distilled water. Each slide was first incubated with proteinase K, after which endogenous peroxidase activity was removed by treatment with 0.3% H2O2 for 20 min at room temperature. After intense washing with distilled water for 15 min, the sections were soaked in TdT buffer for 15 min and then incubated for 60 min at room temperature in TdT buffer containing biotin. The biotinylated dUTP incorporated into the nuclear DNA was reacted with HRP-conjugated streptavidin (1:100 dilution) for 30 min at room temperature, after which the color was developed by immersing the sections for 10 min into 50 mmol/l Tris-HCl buffer (pH 7.6) containing 0.3 mg/ml DAB, 10 mmol/l imidazole and 0.003% H2O2. Finally, the sections were counterstained with hematoxylin. Negative controls were reacted in parallel with the omission of the terminal transferase.
Rat oligonucleotide primer sequences for RT-PCR
Product size Accession No.
Western blot analysis
Western blot analysis was carried out as described previously . Ovaries were homogenized (100 mg wet weight/ml) in ice cold PBS (10 mM sodium phosphate and 150 mM sodium chloride, pH 7.8) containing 0.2% Triton X-100 using a Teflon glass tissue grinder (15 strokes), after which the homogenates were centrifuged (12,000 × g at 4°C for 20 min), and the supernatant fractions were collected for protein assay. Samples of ovarian extract containing 20 μg of protein were then separated by 12.5% SDS-PAGE under reducing conditions and transferred to nitrocellulose membranes using an electroblotting apparatus. Nonspecific binding sites were blocked by incubating the membrane overnight at room temperature in PBS containing 0.05% Tween 20 (TPBS) and 5% skim milk. After five washes for 5 min each in TPBS, the membrane was incubated with the primary antibody (diluted 1:5000 with PBS-BSA for rat adiponectin) for 90 min at room temperature in a humidified chamber. A rat anti-adiponectin antibody was obtained from Abcam (Cambridge, UK). The membrane was then washed again five times for 5 min each in TPBS, incubated with anti-rabbit HRP conjugate (1:5000 dilution) for 50 min at room temperature in a humidified chamber, and finally washed five times for 5 min each in TPBS. For visualization, the blots were incubated with enhanced chemiluminescence reagent (Amersham Pharmacia Biotech UK Ltd., Buckinghamshire, UK) for 1 min and exposed to x-ray film for 15 s in a dark room. The densities of the resultant bands were measured using NIH Image (version 1.61; NIH, Bethesda, MD).
Immunohistochemical analysis was carried out as described previously . Tissues embedded in paraffin were cut into 5-μm-thick sections and mounted on APS-coated glass slides. The slides were then deparaffinized in xylene and placed on a hotplate at 90°C, covered with STUF-solution (Serotec Ltd, UK) for 10 min, rinsed several times with PBS, and incubated in 0.6% H2O2 in methanol for 30 min at room temperature to eliminate endogenous peroxidase activity. The sections were then blocked in Block Ace (Dainippon Pharmaceutical Co, Japan) for 30 min at room temperature, after which they were incubated at room temperature, first with primary antibody (diluted 1:100 with PBS-BSA for adiponectin) for 60 min and then with biotinylated secondary antibody for 30 min. We visualized the labeling using the ABC method (Vectastaign ABC Elite kit; Vector Laboratories, USA) with DAB as a substrate and hematoxylin as a counterstain. As a negative control, some slides were stained with hematoxylin and eosin (HE); alternatively normal rabbit serum was used instead of the primary antibody, or the primary antibody was omitted altogether (data not shown).
Isolated ovaries were fixed for 2 h in 2.5% glutaraldehyde buffered with sodium cacodylate buffer (0.1 M, pH 7.4) and post-fixed for 2 h in 1.0% osmium tetroxide buffered with the same buffer. After dehydration in a graded ethanol series, specimens were placed in Epon 812, cut into semi-thin sections (0.3-0.5 μm) and stained with toluidine blue for light microscopy. Ultrathin sections were then cut, stained using uranyl acetate and lead citrate, and examined in an electron microscope at 125 kV (H-700, Hitachi Japan).
Summary of body weights, estrous cycle and hormonal data for Zucker fa/fa and lean rats
5 weeks of age
8 weeks of age
12 weeks of age
16 weeks of age
Body weight (g)
80.32 +/- 5.80c
128.15 +/- 5.30c
151.61 +/- 8.83c
171.39 +/- 11.34
108.13 +/- 6.78a,c
224.36 +/- 4.46a,c
282.10 +/- 14.61a,c
340.85 +/- 18.38a
% of irregular estrous cycle
5.07 +/- 0.06
3.01 +/- 0.22
4.63 +/- 0.65
5.15 +/- 0.21
2.87 +/- 0.45
3.81 +/- 0.74
0.97 +/- 0.23
1.10 +/- 0.14
1.03 +/- 0.18
1.15 +/- 0.57
1.57 +/- 0.18
1.21 +/- 0.23
13.26 +/- 1.57d
24.45 +/- 1.41c
65.51 +/- 18.07
8.53 +/- 0.29b,d
14.38 +/- 0.98a
17.70 +/- 1.47a
0.16 +/- 0.04c
0.45 +/- 0.02
0.44 +/- 0.08
0.35 +/- 0.16
0.07 +/- 0.01c
0.34 +/- 0.12d
0.28 +/- 0.14b,d
0.16 +/- 0.05b
0.70 +/- 0.35c
1.50 +/- 0.46
1.55 +/- 0.52
1.35 +/- 0.52
0.13 +/- 0.06b,c
0.65 +/- 0.12b,d
0.53 +/- 0.22a,c
0.33 +/- 0.15a
All lean rats had normal 4-day estrous cycles. On the other hand, the estrous cycles of Zucker fatty rats showed increasing irregularity as the rats aged (Table 2), and their diestrous periods were prolonged (data not shown). For example, at 8 weeks of age only one of the seven rats tested showed abnormal estrous cyclicity, but at 16 weeks five of the seven rats showed abnormal estrous cyclicity. Thus the incidence of abnormal cyclicity increased in fatty rats as obesity/insulin resistance became more severe.
In all groups, the fatty rats were significantly heavier than the lean rats (Table 2).
Hormone profile in Zucker fa/fay and lean rats
Hormone assays were carried using serum samples collected from rats at 5, 8, 12 and 16 weeks of age, during diestrous, after they were fasted for 12 h (n = 6 or 7 in each group). In lean rats, serum testosterone increased significantly as they matured during the period from age 5 to 8 weeks, after which the levels remained stable until the rats were 16 weeks of age. In fatty rats, by contrast, serum testosterone significantly declined during the period from age 8 to 16 weeks, and was significantly lower in fatty rats than in lean rats at age 12 and 16 weeks. The serum androstenedione profile was similar to the serum testosterone profile in lean and fatty rats, though serum androstenedione levels were significantly higher in lean rats than fatty rats at all times. In lean rats, serum estradiol levels significantly increased as the rats matured, but in fatty rats estradiol levels remained stable and were significantly lower than in lean rats at all times. There were no differences in FSH or LH levels between fatty and lean rats at any age (Table 2). In addition, although serum adiponectin levels were significantly higher in fatty rats than lean rats, they declined abruptly in fatty rats during the period from age 5 to 8 weeks (Fig. 1).
Expression of adiponectin in ovaries of Zucker fa/fa and lean rats
In 5-week-old rats, ovarian expression of adiponectin mRNA and protein corresponded to the levels of adiponectin in serum; that was not the case at 16 weeks, however. Although ovarian levels of adiponectin mRNA (Fig. 2A) and protein (Fig. 3) were significantly higher in fatty rats than in lean rats at 5 weeks of age, the levels significantly declined in fatty rats as they matured from age 5 to 16 weeks. In lean rats, by contrast, there were no age-dependent changes in adiponectin expression. Consequently, expression of adiponectin was significantly lower in fatty rats than lean rats at 16 weeks.
Expression of adipoR1/R2 in ovaries of Zucker fa/fa and lean rats
The expression patterns of adipoR1 and adipoR2 mRNA were similar. Expression of AdipoR1/R2 mRNA was very low in lean rats at 5 weeks of age, but was significantly (P < 0.01) higher at 16 weeks than at 5 weeks (Fig. 2B, C). By contrast, levels of adipoR1/R2 mRNA expression did not significantly differ between 5- and 16-week-old fatty rats. Moreover, expression of adipoR1/R2 mRNA was significantly (P < 0.05) lower in fatty rats than lean rats at 16 weeks of age.
Ovarian morphology in Zucker fa/fa and lean rats
At 5 weeks of age, the ovaries of fatty rats contained significantly (P < 0.01) larger numbers of antral/preantral follicles than those of lean rats (Fig 4a, b). This prompted us to carry out a TUNEL analysis of the follicles and classify them as atretic if they had five or more apoptotic granulosa cells . We found TUNEL-positive cells to be scattered among the granulosa cells within atretic follicles in both fatty and lean rats; however, the incidence of TUNEL-positivity was significantly higher in the antral/preantral follicles of the fatty rats (Fig. 4). Fatty rats also had slightly greater numbers of healthy follicles than lean rats at this age.
In the present study, we found that ovarian morphology and hormone profiles significantly differed between Zucker fatty and lean rats. As the fatty rats matured and became more obese, they showed follicular atresia, reduced steroidogenesis, abnormal estrous cyclicity and abrupt changes in adiponectin levels. Ovaries from immature (5 weeks of age) fatty rats showed significantly greater total and atretic follicle numbers than ovaries from immature lean rats. By 8 weeks of age estrous cyclicity was abnormal in one of seven fatty rats, and by maturity (12 or 16 weeks of age) ovaries from fatty rats showed attenuated follicle growth and multiple cysts within the interstitial tissue. In addition, the incidence of abnormal estrous cyclicity gradually increased from 28.6% at 12 weeks of age to 71.4% at 16 weeks of age. Immunohistochemical analysis of the cysts indicated they were neither microvessels nor TUNEL-positive atretic follicles.
Devine et al. reported that in Fisher 344 rats, granulosa cells are not seen in atretic follicles, and that the degenerating oocyte becomes segmented, though the zona pellucida remains intact throughout the entire process and continues to enclose the oocyte segments . Our electron microscopic analysis revealed that granulosa cells and the zona pellucida were not present within the cysts in fatty rats, but that they did contain endoplasmic reticulum, mitochondria and microvilli, which might have comprised an oocyte at one time. Despite our negative immunohistochemical and TUNEL findings, this suggests these cysts are follicles at an advanced stage of atresia. It may be that follicular atresia is accelerated in immature fatty rats, which would account for the numerous atretic follicles seen. The atretic follicles in turn become the cysts seen in mature rats. Of course, the morphological changes described above must be associated with alterations in ovarian steroidogenesis. In lean rats, androgen levels significantly increased during the period from age 5 to 8 weeks, after which levels remained stable until 16 weeks. In fatty rats, by contrast, androgen levels significantly declined during the period from age 12 to 16 weeks, during which time follicular atresia progressed. We suggest that the low levels of androgens may reflect the reduction in the numbers of healthy follicles, or androgen synthesis may have declined, even though the number of follicles did not change during the process of follicular atresia. The low androgen levels also might have inhibited follicle growth.
A variety of molecules (glucose and fatty acids, among others) are thought to be directly involved in the regulation of fertility, acting through fuel sensors at every level of the hypothalamo-pituitary-gonadal axis [26, 27]. Our present findings suggest adiponectin may be one of those molecules. We had initially expected that obesity-induced insulin resistance/hyperinsulinemia would stimulate androgen production in Zucker fatty rats, as is seen in polycystic ovary syndrome. Surprisingly, however, serum testosterone and androstenedione significantly declined in fatty rats during the period from age 8 to 16 weeks, though levels remained nearly stable and higher (as compared to fatty rats) in lean rats at the same age. Although it was not proved in this study that adiponectin affects androgen synthesis, Lagaly et al. showed that adiponectin reduces insulin-induced androstenedione production in theca cells . Moreover, it has been proposed in several reports that there is a negative correlation between serum androgen [28, 29] or estradiol  levels and serum adiponectin levels under certain circumstances. It is thus plausible that androgen synthesis is affected by the excessively high serum adiponectin levels seen in immature fatty rats. We therefore suggest that continuously high serum adiponectin levels prior to vaginal opening might downregulate ovarian steroidogenesis. Alternatively, the low ovarian steroidogenesis may contribute to the accelerated follicle atresia see in fatty rats.
In the estrous cycle, circulating reproductive hormones in fatty and lean rats were previously investigated by Whitaker et al.. They reported about plasma estradiol concentration and mentioned that the pattern of estradiol over the estrous cycle was similar in both rats and small difference was found in diestrous, although they did not analyze the statistical significance between fatty and lean rats . In another study they also reported serum FSH, LH, progesterone and prolactin concentrations in fatty rats; proestrous peak concentration of LH was reduced and that of FSH was similar . Above data agree to our hormonal data about FSH, LH and estradiol in diestrous. In addition, they reported progesterone and prolactin concentrations were higher during most of the estrous cycle in fatty rats . Unfortunately, we did not investigate hormonal data at each estrous cycle in this study. However, further studies are needed to clarify complete hormonal status of these rats.
In mature Zucker fatty rats, an abrupt reduction in serum adiponectin appeared to be correlated with acceleration of follicular atresia. Adiponectin is reportedly expressed mainly in theca cells, granulosa cells, oocytes, and corpora lutea in rat ovaries [14, 17]. We found that ovarian expression of adiponectin mRNA and protein was significantly lower in mature fatty rats than immature fatty rats. Moreover, mature fatty rats showed significantly lower ovarian adiponectin levels than lean rats, which is contrary to the situation in serum, where adiponectin levels are higher in fatty rats. This inconsistency between serum and ovarian adiponectin levels in rats has been observed previously , though the underlying mechanism remains unclear. We also observed that in mature fatty rats, the increase in ovarian AdipoR1/R2 expression is significantly attenuated, as compared to lean rats. Adiponectin also plays a role in determining oocyte quality [33, 34] and, as mentioned above, alterations in the ovarian expression of adiponectin and its receptor system could affect ovarian steroidogenesis in granulosa and theca cells in fatty rats. Collectively then, our findings suggest the reduction in ovarian steroidogenesis is related to the changes in ovarian morphology seen in Zucker fatty rats, including the reductions in the numbers of healthy follicles and in ovarian adiponectin production.
We have shown that ovarian morphology and androgen profiles differ substantially between Zucker fatty and lean rats, and that the reproductive abnormalities seen in the fatty rats gradually worsen as the rats mature. As obesity/insulin resistance became more severe in the fatty rats, androgen levels declined and follicular atresia accelerated. This was accompanied by dramatically altered adiponectin levels and a higher incidence of abnormal cyclicity. The precise effects of these adiponectin alterations on ovarian function, and thus the cause of infertility in Zucker fatty rats, remain to be determined.
This study was supported by a Grant-in-Aid for Scientific Research (C) 16591676 of the Ministry of Education, Science and Culture of Japan (to T. Endo).
- Penicaud L, Ferre P, Terretaz J, Kinebanyan MF, Leturque A, Dore E, Girard J, Jeanrenaud B, Picon L: Development of obesity in Zucker rats. Early insulin resistance in muscles but normal sensitivity in white adipose tissue. Diabetes. 1987, 36: 626-631. 10.2337/diabetes.36.5.626.View ArticlePubMedGoogle Scholar
- Bray GA: The Zucker-fatty rat: a review. Fed Proc. 1977, 36: 148-153.PubMedGoogle Scholar
- Zucker LM, Antoniades HN: Insulin and obesity in the Zucker genetically obese "fatty" rat. Endocrinology. 1972, 90: 1320-1330. 10.1210/endo-90-5-1320.View ArticlePubMedGoogle Scholar
- Stern J, Johnson PR, Greenwood MR, Zucker LM, Hirsch J: Insulin resistance and pancreatic insulin release in the genetically obese Zucker rat. Proc Soc Exp Biol Med. 1972, 139: 66-69.View ArticlePubMedGoogle Scholar
- Marin Bivens CL, Olster DH: Abnormal estrous cyclicity and behavioral hyporesponsiveness to ovarian hormones in genetically obese Zucker female rats. Endocrinology. 1997, 138: 143-148. 10.1210/en.138.1.143.PubMedGoogle Scholar
- Hotta K, Funahashi T, Arita Y, Takahashi M, Matsuda M, Okamoto Y, Iwahashi H, Kuriyama H, Ouchi N, Maeda K, Nishida M, Kihara S, Sakai N, Nakajima T, Hasegawa K, Muraguchi M, Ohmoto Y, Nakamura T, Yamashita S, Hanafusa T, Matsuzawa Y: Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol. 2000, 20: 1595-1599.View ArticlePubMedGoogle Scholar
- Stefan N, Stumvoll M: Adiponectin--its role in metabolism and beyond. Horm Metab Res. 2002, 34: 469-474. 10.1055/s-2002-34785.View ArticlePubMedGoogle Scholar
- Matsubara M, Maruoka S, Katayose S: Decreased plasma adiponectin concentrations in women with dyslipidemia. J Clin Endocrinol Metab. 2002, 87: 2764-2769. 10.1210/jc.87.6.2764.View ArticlePubMedGoogle Scholar
- Kazumi T, Kawaguchi A, Sakai K, Hirano T, Yoshino G: Young men with high-normal blood pressure have lower serum adiponectin, smaller LDL size, and higher elevated heart rate than those with optimal blood pressure. Diabetes Care. 2002, 25: 971-976. 10.2337/diacare.25.6.971.View ArticlePubMedGoogle Scholar
- Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, Hotta K, Shimomura I, Nakamura T, Miyaoka K, Kuriyama H, Nishida M, Yamashita S, Okubo K, Matsubara K, Muraguchi M, Ohmoto Y, Funahashi T, Matsuzawa Y: Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun. 1999, 257: 79-83. 10.1006/bbrc.1999.0255.View ArticlePubMedGoogle Scholar
- Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley RE, Tataranni PA: Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab. 2001, 86: 1930-1935. 10.1210/jc.86.5.1930.View ArticlePubMedGoogle Scholar
- Lin LY, Lin CY, Su TC, Liau CS: Angiotensin II-induced apoptosis in human endothelial cells is inhibited by adiponectin through restoration of the association between endothelial nitric oxide synthase and heat shock protein 90. FEBS Lett. 2004, 574: 106-110. 10.1016/j.febslet.2004.08.012.View ArticlePubMedGoogle Scholar
- Oana F, Takeda H, Hayakawa K, Matsuzawa A, Akahane S, Isaji M, Akahane M: Physiological difference between obese (fa/fa) Zucker rats and lean Zucker rats concerning adiponectin. Metabolism. 2005, 54: 995-1001. 10.1016/j.metabol.2005.02.016.View ArticlePubMedGoogle Scholar
- Caminos JE, Nogueiras R, Gaytan F, Pineda R, Gonzalez CR, Barreiro ML, Castano JP, Malagon MM, Pinilla L, Toppari J, Diéguez C, Tena-Sempere M: Novel expression and direct effects of adiponectin in the rat testis. Endocrinology. 2008, 149: 3390-3402. 10.1210/en.2007-1582.View ArticlePubMedGoogle Scholar
- Chabrolle C, Tosca L, Dupont J: Regulation of adiponectin and its receptors in rat ovary by human chorionic gonadotrophin treatment and potential involvement of adiponectin in granulosa cell steroidogenesis. Reproduction. 2007, 133: 719-731. 10.1530/REP-06-0244.View ArticlePubMedGoogle Scholar
- Chabrolle C, Jeanpierre E, Tosca L, Rame C, Dupont J: Effects of high levels of glucose on the steroidogenesis and the expression of adiponectin receptors in rat ovarian cells. Reprod Biol Endocrinol. 2008, 6: 11-10.1186/1477-7827-6-11.PubMed CentralView ArticlePubMedGoogle Scholar
- Lagaly DV, Aad PY, Grado-Ahuir JA, Hulsey LB, Spicer LJ: Role of adiponectin in regulating ovarian theca and granulosa cell function. Mol Cell Endocrinol. 2008, 284: 38-45. 10.1016/j.mce.2008.01.007.View ArticlePubMedGoogle Scholar
- Mahesh VB, Mills TM, Bagnell CA, Conway BA: Animal models for study of polycystic ovaries and ovarian atresia. Adv Exp Med Biol. 1987, 219: 237-257.View ArticlePubMedGoogle Scholar
- Anderson E, Lee GY: The effects of dehydroepiandrosterone (DHEA) and its metabolites on the polycystic ovarian condition (PCO): cystogenic changes of rat granulosa cells in vitro. Tissue Cell. 1996, 28: 673-685. 10.1016/S0040-8166(96)80071-1.View ArticlePubMedGoogle Scholar
- Anderson E, Lee GY: The polycystic ovarian (PCO) condition: apoptosis and epithelialization of the ovarian antral follicles are aspects of cystogenesis in the dehydroepiandrosterone (DHEA)-treated rat model. Tissue Cell. 1997, 29: 171-189. 10.1016/S0040-8166(97)80017-1.View ArticlePubMedGoogle Scholar
- Henmi H, Endo T, Nagasawa K, Hayashi T, Chida M, Akutagawa N, Iwasaki M, Kitajima Y, Kiya T, Nishikawa A, Manase K, Kudo R: Lysyl oxidase and MMP-2 expression in dehydroepiandrosterone-induced polycystic ovary in rats. Biol Reprod. 2001, 64: 157-162. 10.1095/biolreprod64.1.157.View ArticlePubMedGoogle Scholar
- Honnma H, Endo T, Henmi H, Nagasawa K, Baba T, Yamazaki K, Kitajima Y, Hayashi T, Manase K, Saito T: Altered expression of Fas/Fas ligand/caspase 8 and membrane type 1-matrix metalloproteinase in atretic follicles within dehydroepiandrosterone-induced polycystic ovaries in rats. Apoptosis. 2006, 11: 1525-1533. 10.1007/s10495-006-9148-2.View ArticlePubMedGoogle Scholar
- Kitajima Y, Endo T, Nagasawa K, Manase K, Honnma H, Baba T, Hayashi T, Chiba H, Sawada N, Saito T: Hyperstimulation and a gonadotropin-releasing hormone agonist modulate ovarian vascular permeability by altering expression of the tight junction protein claudin-5. Endocrinology. 2006, 147: 694-699. 10.1210/en.2005-0700.View ArticlePubMedGoogle Scholar
- Hamm ML, Bhat GK, Thompson WE, Mann DR: Folliculogenesis is impaired and granulosa cell apoptosis is increased in leptin-deficient mice. Biol Reprod. 2004, 71: 66-72. 10.1095/biolreprod.104.027292.View ArticlePubMedGoogle Scholar
- Devine PJ, Payne CM, McCuskey MK, Hoyer PB: Ultrastructural evaluation of oocytes during atresia in rat ovarian follicles. Biol Reprod. 2000, 63: 1245-1252. 10.1095/biolreprod63.5.1245.View ArticlePubMedGoogle Scholar
- Butler WR: Nutritional interactions with reproductive performance in dairy cattle. Anim Reprod Sci. 2000, 60-61: 449-457. 10.1016/S0378-4320(00)00076-2.View ArticlePubMedGoogle Scholar
- Fernandez-Fernandez R, Martini AC, Navarro VM, Castellano JM, Dieguez C, Aguilar E, Pinilla L, Tena-Sempere M: Novel signals for the integration of energy balance and reproduction. Mol Cell Endocrinol. 2006, 254-255: 127-132. 10.1016/j.mce.2006.04.026.View ArticlePubMedGoogle Scholar
- Resmini E, Andraghetti G, Rebora A, Cordera R, Vera L, Giusti M, Minuto F, Ferone D: Leptin, ghrelin, and adiponectin evaluation in transsexual subjects during hormonal treatments. J Androl. 2008, 29: 580-585. 10.2164/jandrol.108.004952.View ArticlePubMedGoogle Scholar
- Nishizawa H, Shimomura I, Kishida K, Maeda N, Kuriyama H, Nagaretani H, Matsuda M, Kondo H, Furuyama N, Kihara S, Nakamura T, Tochino Y, Funahashi T, Matsuzawa Y: Androgens decrease plasma adiponectin, an insulin-sensitizing adipocyte-derived protein. Diabetes. 2002, 51: 2734-2741. 10.2337/diabetes.51.9.2734.View ArticlePubMedGoogle Scholar
- Luque-Ramirez M, Alvarez-Blasco F, Escobar-Morreale HF: Antiandrogenic contraceptives increase serum adiponectin in obese polycystic ovary syndrome patients. Obesity (Silver Spring). 2009, 17: 3-9. 10.1038/oby.2008.491.View ArticleGoogle Scholar
- Whitaker EM, Shaw MA, Hervey GR: Plasma oestradiol-17 beta and testosterone concentrations as possible causes of the infertility of congenitally obese Zucker rats. J Endocrinol. 1983, 99: 485-490. 10.1677/joe.0.0990485.View ArticlePubMedGoogle Scholar
- Whitaker EM, Robinson AC: Circulating reproductive hormones and hypothalamic oestradiol and progestin receptors in infertile Zucker rats. J Endocrinol. 1989, 120: 331-336. 10.1677/joe.0.1200331.View ArticlePubMedGoogle Scholar
- Mitchell M, Armstrong DT, Robker RL, Norman RJ: Adipokines: implications for female fertility and obesity. Reproduction. 2005, 130: 583-597. 10.1530/rep.1.00521.View ArticlePubMedGoogle Scholar
- Maillard V, Uzbekova S, Guignot F, Perreau C, Rame C, Coyral Castel S, Dupont J: Effect of adiponectin on bovine granulosa cell steroidogenesis, oocyte maturation and embryo development. Reprod Biol Endocrinol. 8: 23-10.1186/1477-7827-8-23.Google Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.